17/08/2001 (Agence Europe) - In a note on the affair of the withdrawal by Bayer of cerivastatin-based anti-cholesterol medicines, said to be responsible for several deaths (see yesterday's EUROPE, p.1), the European Commission stipulates that, in June, the early warning system provided for by the European Agency for the Evaluation of Medicines was triggered in time. Indeed, it was at the request of the European "Pharmacovigilance" working party, created within the Agency, that Bayer had...